Why the study?
Little research has used resting-state functional connectivity to examine default mode network synchrony during opioid use and cessation.
Does resting-state functional connectivity in the DMN differ between active opioid use and cessation in treatment-seeking persons with opioid use disorder?
Does resting-state functional connectivity in the DMN differ between active opioid use and cessation in treatment-seeking persons with opioid use disorder?
Functional connectivity in the default mode network increases during opioid cessation compared to active use and strongly predicts withdrawal symptom severity.
DMN connectivity shifts during opioid use versus cessation are hypothesis-generating; leaves open links to treatment outcomes in larger trials.
Resting-state functional connectivity analyses have been used to examine synchrony in neural networks in substance use disorders (SUDs), with the default mode network (DMN) one of the most studied. Prior research has generally found less DMN synchrony during use and greater synchrony during cessation, although little research has utilized this method with opioid use. This study examined resting brain activity in treatment-seeking persons who use opioids at two points-when using opioids and when opioid-free-to determine whether the DMN exhibits different levels of connectivity during opioid use and cessation and whether differences in connectivity predict subsequent relapse. The sample included 11 participants who met DSM-5 criteria for opioid use disorder and initiated buprenorphine treatment following fMRI scans that were approximately 3 days apart. Results showed greater functional connectivity in the DMN and the rIFG of the salience network (SN) when participants were abstaining than when actively using opioids. These changes in connectivity predicted 76.2% of the variance in withdrawal symptom severity, with the DMN nodes accounting for an additional 30.9%. Findings warrant further longitudinal exploration of the role of DMN connectivity and its interactions with other networks in relation to abstinence and withdrawal status and examination of its utility as a prognostic marker of cessation or relapse.
No takes yet. Share an insight, caveat, or question.
Dandurand et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: